The Role of [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography and [<sup>111</sup>In]-Diethylenetriaminepentaacetate-<scp>d</scp>-Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing’s Syndrome

Karel Pacák(National Institutes of Health), Lynnette K. Nieman(National Institutes of Health), Ιoannis Ilias(Hippocration General Hospital), Clara C. Chen(United States Nuclear Regulatory Commission), Jorge A. Carrasquillo(Memorial Sloan Kettering Cancer Center), Millie Whatley(United States Nuclear Regulatory Commission)
The Journal of Clinical Endocrinology & Metabolism
May 1, 2004
Cited by 138


Related Papers